CPT1A and head and neck squamous cell carcinoma: This promotes the contacting of lipid droplets and mitochondria in HNSCC cells through the binding of PLIN2 and CPT1A and reverses cisplatin-induced ROS elevation, which preliminarily explains why cervical lymph node metastases are prone to cisplatin resistance and provides a potential target for future therapy.